BullFrog AI Holdings, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
NV
Business Address
325 ELLINGTON BLVD., GAITHERSBURG, MD, 20878
Mailing Address
325 ELLINGTON BLVD., GAITHERSBURG, MD, 20878
Phone
3013672055
Fiscal Year End
1231
EIN
844786155
Financial Overview
FY2025
$-0.63
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | April 13, 2026 | View on SEC |
| 424B5 Prospectus supplement | April 1, 2026 | View on SEC |
| 8-K Current report of material events | April 1, 2026 | View on SEC |
| 8-K Current report of material events | March 30, 2026 | View on SEC |
| 10-K Annual financial report | March 19, 2026 | View on SEC |
| 8-K Current report of material events | February 23, 2026 | View on SEC |
| 8-K Current report of material events | February 17, 2026 | View on SEC |
| 8-K Current report of material events | December 30, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| 424B5 Prospectus supplement | November 7, 2025 | View on SEC |
Annual Reports
10-K
March 19, 2026
- Proprietary bfLEAP™ AI platform for drug discovery, development, and patient reaction prediction.
- Secured sole global licenses for promising drug candidates (Mebendazole for glioblastoma, prodrugs, Beta2 Spectrin siRNA).
Material Events
8-K
Financial Distress
April 1, 2026
High Impact
- Regained Nasdaq listing compliance, eliminating immediate delisting risk
- Successfully raised $3.45 million in capital to bolster shareholder equity
8-K
Financial Distress
February 23, 2026
High Impact
- BullFrog AI leverages AI for drug discovery, operating in a high-potential sector.
- The company plans to request a hearing before an independent Nasdaq Hearings Panel, temporarily halting the delisting process.
8-K
Financial Distress
February 17, 2026
High Impact
- BullFrog AI leverages Artificial Intelligence (AI) for drug discovery, a promising and innovative field.
- The company has stated its intention to monitor its stock price and evaluate all available options to restore Nasdaq compliance.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.